862TiPReCab II: A phase II trial of Cabazitaxel +/- Rhenium -188-HEDP in patients with metastatic castration resistant prostate cancer who progressed on or after a docetaxel containing treatment. (23rd October 2018) - Bouman-Wammes, E; van Dodewaard-De Jong, J M; Bloemendal, H; Verheul, H M; de Klerk, J M H; van den Eertwegh, A J M